Monash IVF Group Limited chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 0.50
Dividend & Yield0.04$ (4.27%)
Beta 1.74
Market capitalization 389.64M
Operating cash flow 37.94M
ESG Scores unknown

Company description

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility research and treatment services. It also provides tertiary level prenatal diagnostic and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Richmond, Australia.

Sector: Healthcare - Industry: Diagnostics & Research

Financial data

Financial Statements

Cashflow Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Change To Liabilities -3.55M 1.63M 5.09M -1.96M
Total Cashflows From Investing Activities -6.56M -6.54M -10.56M -11.29M
Net Borrowings 2.5M -9M -76.92M -25.22M
Total Cash From Financing Activities -19.26M -26.11M -9.7M -39.08M
Change To Operating Activities 445k 769k 987k 1.47M
Issuance Of Stock 77.53M 77.53M 77.53M
Net Income 21.35M 19.85M 11.73M 25.15M
Change In Cash 351k 428k 10.79M -6.31M
Effect Of Exchange Rate 240k -15k -23k
Total Cash From Operating Activities 25.93M 33.09M 31.08M 44.05M
Depreciation 3.89M 3.71M 9.11M 10.7M
Change To Account Receivables 923k 316k -3.81M 640k
Other Cashflows From Financing Activities -3.16M -3.92M -3.24M -725k
Change To Netincome 2.25M 4.87M 6.94M 2.23M
Capital Expenditures -6.56M -6.54M -7.51M -10.03M

Income Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Research Development
Income Before Tax 29.61M 27.48M 16.13M 35.94M
Net Income 21.35M 19.85M 11.73M 25.15M
Selling General Administrative 16.93M 11.01M 12.29M 14.3M
Gross Profit 59.94M 52.85M 50.92M 66.4M
Ebit 33.16M 32.74M 22.37M 34.01M
Operating Income 33.16M 32.74M 22.37M 34.01M
Interest Expense -3.44M -3.81M -5.72M -2.45M
Income Tax Expense 8.42M 7.68M 4.37M 10.44M
Total Revenue 150.64M 151.98M 145.42M 183.6M
Cost Of Revenue 90.7M 99.13M 94.49M 117.21M
Total Other Income ExpenseNet -3.55M -5.26M -6.25M 1.93M
Net Income From Continuing Ops 21.18M 19.81M 11.76M 25.5M
Net Income Applicable To Common Shares 21.35M 19.85M 11.73M 25.15M

Balance Sheet Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Total Liabilities 123.75M 116.6M 96.91M 82.23M
Total Stockholder Equity 166.59M 173.22M 249.81M 266.68M
Other Current Liabilities 6.46M 6.32M 12.28M 11.64M
Total Assets 290.61M 290.04M 349.03M 351.17M
Common Stock 428.35M 428.76M 506.79M 506.79M
Other Current Assets
Retained Earnings -124.72M -118.06M -120.2M -103.23M
Treasury Stock -137.03M -137.48M -136.78M -136.87M
Cash 3.85M 4.28M 15.07M 8.76M
Total Current Liabilities 21.97M 24.2M 37.86M 41.08M
Other Stockholder Equity -137.03M -137.48M -136.78M -136.87M
Property, Plant, and Equipment 16.93M 16.52M 55.62M 67.29M
Total Current Assets 16.73M 15.53M 30.66M 22.5M
Net Tangible Assets -89.52M -83.89M -12.36M 6.7M
Net Receivables 6.77M 4.94M 8.88M 6.58M
Accounts Payable 2.8M 4.39M 3.02M 2.25M


Insider Transactions

Here are the insider transactions of stock shares related to Monash IVF Group Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Hamilton (Hamish)D2021-06-30Chief Operating Officer52.3k
West (Catherine Jane)Purchase at price 0.70 per share.D2021-04-27Independent Non-Executive Director33.3k
Broekhuizen (Neil John)Purchase at price 0.69 per share.D2021-04-26Independent Non-Executive Director217.21k
West (Catherine Jane)Purchase at price 0.69 per share.D2021-04-26Independent Non-Executive Director3.8k
Boyce (Christina)D2020-06-29Former154.32k
Boyce (Christina)Other at price 0.34 per share.D2020-05-27Director (Independent)38.1k
Broekhuizen (Neil John)Other at price 0.34 per share.D2020-05-27Independent Non-Executive Director32.79k
Czyzewski (Josef Jerry)Other at price 0.34 per share.D2020-05-27Independent Non-Executive Director52.46k
Czyzewski (Josef Jerry)Other at price 0.34 per share.D2020-05-27Independent Non-Executive Director26.89k
Davis (Richard Hugh)Other at price 0.34 per share.D2020-05-27Independent Chairman Of The Board44.95k
Henshaw (Richard Charles)Other at price 0.34 per share.D2020-05-27Director (Executive)335.52k
Knaap (Michael)Other at price 0.34 per share.D2020-05-27Chief Executive Officer59.67k
Peach (Zita)Other at price 0.34 per share.D2020-05-27Independent Non-Executive Director22.91k
Peach (Zita)Purchase at price 0.46 per share.D2020-04-16Independent Non-Executive Director13.89k
Czyzewski (Josef Jerry)Purchase at price 0.52 per share.D2020-03-11Independent Non-Executive Director17.93k
Czyzewski (Josef Jerry)Purchase at price 0.51 per share.D2020-03-10Independent Non-Executive Director2.07k
Knaap (Michael)Purchase at price 0.54 per share.D2020-03-09Chief Executive Officer36.55k
Henshaw (Richard Charles)D2019-10-22Director (Executive)388.31k
Davis (Richard Hugh)Purchase at price 0.70 per share.D2019-09-13Independent Chairman Of The Board34.31k
Davis (Richard Hugh)Purchase at price 0.69 per share.D2019-09-02Independent Chairman Of The Board50k
Boyce (Christina)Purchase at price 0.68 per share.D2019-08-28Director (Independent)10k
Knaap (Michael)D2019-04-15Chief Executive Officer7.77k
Henshaw (Richard Charles)Purchase at price 0.71 per share.D2018-11-26Director (Executive)19.51k
Henshaw (Richard Charles)Purchase at price 0.71 per share.D2018-11-23Director (Executive)151.51k
Henshaw (Richard Charles)Purchase at price 0.72 per share.D2018-11-23Director (Executive)132k
Boyce (Christina)Purchase at price 0.66 per share.D2018-10-22Director (Independent)40k
Davis (Richard Hugh)Purchase at price 0.69 per share.D2018-10-17Independent Chairman Of The Board25.77k
Peach (Zita)Purchase at price 0.67 per share.D2018-10-11Independent Non-Executive Director27.26k
Boyce (Christina)Purchase at price 0.67 per share.D2018-10-10Director (Independent)10k
Czyzewski (Josef Jerry)Purchase at price 0.67 per share.D2018-10-10Independent Non-Executive Director10k
Czyzewski (Josef Jerry)Purchase at price 0.68 per share.D2018-10-10Independent Non-Executive Director10k
Morris (David N.)Purchase at price 0.91 per share.D2017-12-12Chief Executive Officer1k
Morris (David N.)Purchase at price 0.91 per share.D2017-12-11Chief Executive Officer14.64k
Morris (David N.)Purchase at price 0.91 per share.D2017-12-08Chief Executive Officer9k
Morris (David N.)Purchase at price 0.91 per share.D2017-12-07Chief Executive Officer357
Morris (David N.)Sale at price 0.92 per share.D2017-11-30Chief Executive Officer10k
Boyce (Christina)Purchase at price 0.95 per share.D2017-11-29Director (Independent)15k
Morris (David N.)Purchase at price 0.95 per share.D2017-11-29Chief Executive Officer10k
Boyce (Christina)Purchase at price 0.95 per share.D2017-11-28Director (Independent)15k
Morris (David N.)Purchase at price 0.94 per share.D2017-11-28Chief Executive Officer12.35k
Morris (David N.)Purchase at price 0.96 per share.D2017-11-27Chief Executive Officer67.65k
Peach (Zita)Purchase at price 0.99 per share.D2017-11-27Independent Non-Executive Director15.4k
Henshaw (Richard Charles)Sale at price 1.83 per share.D2016-09-28Director (Executive)76.76k
Henshaw (Richard Charles)Sale at price 1.77 per share.D2016-09-27Director (Executive)545.66k
Henshaw (Richard Charles)Sale at price 1.77 per share.D2016-09-26Director (Executive)283.94k
Thiedeman (Benjamin James)Sale at price 1.73 per share.D2016-09-16Chief Executive Officer252k
Fox (Rodney)D2016-06-30Former138.43k
Lane (Michelle)D2016-06-30Former813.91k
Czyzewski (Josef Jerry)Purchase at price 0.88 per share.D2015-09-02Director (Independent)25k
Czyzewski (Josef Jerry)Purchase at price 0.83 per share.D2015-08-31Director (Independent)35k
Boyce (Christina)Purchase at price 1.21 per share.D2014-10-30Director (Independent)10k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Monash IVF Group Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Monash IVF Group Limited

Here is the result of two systematic investment strategies applied to Monash IVF Group Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Monash IVF Group Limited

The following chart shows the equity curve of the two systematic investment strategies applied to Monash IVF Group Limited:

Monash IVF Group Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -25.04% on the backtest period.

Performance at glance

Performance

-25.04 %

Latent gain

-563.29 $

Invested capital

2249.29 $

Annualized return

-6.11 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Monash IVF Group Limited

This is the result of two momentum investment strategies applied to Monash IVF Group Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Monash IVF Group Limited

The following chart shows all the entries opened by the momentum investment system on Monash IVF Group Limited:

Monash IVF Group Limited momentum entries
  • The first momentum investment strategy would give -11.92% of return on Monash IVF Group Limited. That represents -595.84$ of latent gain with 5000.59$ of employed capital.
  • The second momentum investment strategy would give -14.89% of return on Monash IVF Group Limited. That represents -446.7$ of latent gain with 3000.45$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-11.92 %

Latent gain

-595.84 $

Invested capital

5000.59 $

Annualized return

-11.72 %
Performance at glance (2Q Momentum)

Performance

-14.89 %

Latent gain

-446.7 $

Invested capital

3000.45 $

Annualized return

-4.11 %

Momentum equity curve on Monash IVF Group Limited

The following chart shows the equity curve of the two momentum strategies applied to Monash IVF Group Limited:

Monash IVF Group Limited momentum equity

Note: the dividends potentially given by Monash IVF Group Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Monash IVF Group Limited

The following chart shows the employed capital evolution of the two momentum strategies on Monash IVF Group Limited since the beginning:

Monash IVF Group Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Monash IVF Group Limited

Buy the dip entry openings on Monash IVF Group Limited

Monash IVF Group Limited

The performance achieved by the robo-advisor on Monash IVF Group Limited is -24.62%. That represents -61.5$ of latent gain with 249.75$ of employed capital. The following chart shows Monash IVF Group Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Monash IVF Group Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-24.62 %

Latent gain

-61.5 $

Invested capital

249.75 $

Annualized return

-11.72 %

Equity curve of the strategy applied to Monash IVF Group Limited

The following chart shows the result of the investment strategy applied to Monash IVF Group Limited:

Monash IVF Group Limited

Note: the dividends potentially given by Monash IVF Group Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Monash IVF Group Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on Monash IVF Group Limited:

Monash IVF Group Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Monash IVF Group Limited

In this section, I will compare the three previous investment strategies applied to Monash IVF Group Limited.

Equity curve comparison on Monash IVF Group Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Monash IVF Group Limited investment strategy comparison

Employed capital comparison on Monash IVF Group Limited

Monash IVF Group Limited investment comparison

Performance comparison on Monash IVF Group Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -25.04% -563.29$ 2249.29$ -6.11%
Momentum 1 quarter -11.92% -595.84$ 5000.59$ -3.09%
Momentum 2 quarters -14.89% -446.7$ 3000.45$ -4.11%
Non-directional -24.62% -61.5$ 249.75$ -11.72%
Annualized return comparison

Automatic investment

-6.11 %

Momentum 1Q

-4.11 %

Momentum 2Q

-4.11 %

Non-directional

-11.72 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Monash IVF Group Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Monash IVF Group Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of Monash IVF Group Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Monash IVF Group Limited
Country Australia
City Richmond
Address Pelaco Building 1
Phone 61 3 9420 8235
Website www.monashivfgroup.com.au
FullTime employees 669
Industry Diagnostics & Research
Sector Healthcare
Exchange XASX
Ticker MVF.XASX
Market www2.asx.com.au

Monash IVF Group Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown